Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenues:
Total revenues	$ 198,962	$ 99,770	$ 75,442
Expenses:
Cost of goods sold	20,863	16,003	16,833
Research and development	31,283	19,721	12,312
Selling	51,776	53,753	45,528
General and administrative	42,538	37,720	31,889
Asset impairment			106
Loss (gain) on foreign currency transaction	1,916	(4,811)	(6,567)
Loss on purchase commitments			339
Total expenses	190,284	163,880	122,464
Income (loss) from operations	8,678	(64,110)	(47,022)
Other income (expense):
Interest income, net	6,154	2,513	112
Interest expense on financing liability	(9,825)	(9,758)	(1,373)
Interest expense	(15,151)	(15,011)	(15,204)
Interest expense on liability for sale of future royalties	(185)
Loss on available-for-sale securities	(170)	(932)
Loss on extinguishment of debt			(17,200)
Other income (expense)	122	(102)	(239)
Total other expense	(19,055)	(23,290)	(33,904)
Loss before income tax expense	(10,377)	(87,400)	(80,926)
Income tax expense	(1,561)
Net loss	$ (11,938)	$ (87,400)	$ (80,926)
Net loss per share - basic	$ (0.04)	$ (0.34)	$ (0.32)
Net loss per share - diluted	$ (0.04)	$ (0.34)	$ (0.32)
Weighted average shares used to compute net loss per share - basic	267,014	257,092	249,244
Weighted average shares used to compute net loss per share - diluted	267,014	257,092	249,244
Commercial product sales
Revenues:
Total revenues	$ 74,029	$ 56,247	$ 39,168
Collaborations and services
Revenues:
Total revenues	52,954	27,924	36,274
Expenses:
Cost of revenue	41,908	41,494	$ 22,024
Royalties
Revenues:
Total revenues	$ 71,979	$ 15,599